MoneyWorks4Me

Gujarat Inject (Kerala) informs about outcome of board meeting

31 Oct 2022 Evaluate

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Gujarat Inject (Kerala) has informed that the Board of Directors of the Company in their Meeting held today October 31, 2022 at the Administrative Office of the Company at SB-06, Paradise Complex, Opp. M.S. University, Sayajiganj, Vadodara - 390005 Gujarat India which commenced at 03:00 pm and concluded at 03.15 pm to took note of the withdrawal of the Issue of Convertible Equity Warrants (‘Warrants/Convertible Warrants’) on preferential basis approved in the board meeting dated September 14, 2022 due to postponement of object of the Issue.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..